Skip to content

Case report, 2022

Does sertraline help women with severe premenstrual dysphoric disorder?

In this case, a 44-year-old woman with severe PMDD symptoms showed complete recovery after taking sertraline for two menstrual cycles, and was able to continue taking it just during the week before menstruation.

Early or limited evidence One 44-year-old woman with severe premenstrual dysphoric disorder.

What they did

Doctors described one 44-year-old woman with premenstrual dysphoric disorder who was treated with sertraline, a type of antidepressant. A literature review of PMDD treatment accompanied the case description.

What they found

The woman had experienced abdominal pain, anxiety, obsessive thoughts, sadness, emotional instability, lack of motivation, low energy, uncontrolled impulses, irritability and aggressive outbursts only during the week before menstruation for several years. These symptoms harmed her relationships. After starting sertraline, she recovered completely after two menstrual cycles. Six months later, she was taking sertraline only during the week before menstruation and remained stable.

What it means for you

This case shows that sertraline can help severe PMDD symptoms. Some women may be able to take it only during the week before menstruation after an initial period of daily treatment. The main limitation is that this is one woman, so we cannot know how many women would respond this way or whether this approach works for everyone.

44

woman's age in years

2 cycles

time to complete recovery

1.8-5.8%

prevalence of PMDD in the population

About the study

Original title
Antidepressant treatment in premenstrual dysphoric disorder, case report
Authors
Garcia Moreno M, De Cos Milas A, Beatobe Carreño L et al.
Journal
European psychiatry : the journal of the Association of European Psychiatrists
Year
2022
Study design
Case report
What was tested
Sertraline (an antidepressant), initially daily then during the week before menstruation only.
Open access
Yes
Original abstract

Introduction: Premenstrual dysphoric disorder (PMDD) is included for the first time in the last edition of DSM within affective disorders. It is necessary that 5 of a list of 11 symptoms (lability, irritability, depressed mood, anxiety, lethargy, being out of control or physical symptoms among others) appear in the majority of menstrual cycles but must be only present during the week before menstruation improving after its onset. It has a prevalence of 1,8-5,8% and it is associated to significant functional impairment. SSRIs are indicated as first-line treatment in severe symptoms. Objectives: To review about premenstrual dysphoric disorder and its psychopharmacological treatment. Methods: We carry out a literature review about premenstrual dysphoric disorder, accompanied by a clinical description of one patient treated with sertraline. Results: 44 years old female referred to our outpatient mental health service due to anxious and depressive symptoms. She had presented abdominal pain, anxiety, obsessive thoughts, sadness, emotional lability, apahty, anergy, uncontrolled impulse, irritability and vociferous attitude with verbal agressiveness only the week before menstruation during several years. These symptoms interfered negatively in her relationships. We started sertraline treatment with ad integrum clinical recovery after two menstrual cycles. 6 months later we indicated to take sertraline only the week before menstruation, maintaining stability. Conclusions: 1) It is important to consider premenstrual dysphoric disorder as a possible diagnosis in women with premenstrual discomfort symptoms. 2) It might be consider as a depressive disorder. 3) Antidepressant treatment should be considered in women with disabling symptoms. Disclosure: No significant relationships.

Reproduced under CC-BY.

Topics